Clinical Trial Update: Henagliflozin in Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for henagliflozin in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Henagliflozin (henagliflozin)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN